REVIEW ON: ANTICOAGULATION THERAPY

Anticoagulation drugs antagonize coagulation and are used to prevent or cure venous thromboembolism (VTE). Drug to prevent clotting have been used for more then a century. Within this review, we aimed to revise the history of the different anticoagulation that are currently prescribe in the clinic. In addition, we compared their pharmacology properties, medical indication and the difficulties in implementing new anticoagulation in vulnerable patient population. Since the introduction of unfractionated heparin in the 1930s, major advance in the mechanistic understanding and medicinal use of anticoagulation have allowed for significant improvement in treating VTE patient. However, a new generation of anticoagulation is currently being tested in clinical trials, with the goal of further optimizing medical care.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-01-16
DOI
https://doi.org/10.5281/zenodo.18255187
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

REVIEW ON: ANTICOAGULATION THERAPY

*1Tejas Talan, 2Dr. Karishma Nikose, 3Sanjiwani Pawar, 4Achal Mandale, 5Siddesh Lande
Zenodo (CERN European Organization for Nuclear Research)
Venous Thromboembolism Diagnosis and Management
article

REVIEW ON: ANTICOAGULATION THERAPY

*1Tejas Talan, 2Dr. Karishma Nikose, 3Sanjiwani Pawar, 4Achal Mandale, 5Siddesh Lande
article en

Abstract

Anticoagulation drugs antagonize coagulation and are used to prevent or cure venous thromboembolism (VTE). Drug to prevent clotting have been used for more then a century. Within this review, we aimed to revise the history of the different anticoagulation that are currently prescribe in the clinic. In addition, we compared their pharmacology properties, medical indication and the difficulties in implementing new anticoagulation in vulnerable patient population. Since the introduction of unfractionated heparin in the 1930s, major advance in the mechanistic understanding and medicinal use of anticoagulation have allowed for significant improvement in treating VTE patient. However, a new generation of anticoagulation is currently being tested in clinical trials, with the goal of further optimizing medical care.

Zenodo (CERN European Organization for Nuclear Research)
No poverty, Good health and well-being
Openalex Percentile: Top 89%
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.